A critical discovery in cancer investigation is arising with the use of mini-antibodies to reactivate dysfunctional p53. This essential cancer suppressor protein is frequently lost in several kinds of cancer, resulting https://bookmarksusa.com/story22027731/nanobodies-reactivate-tumor-suppressor-p53-the-new-pathway-for-tumor-treatment